Table 2.
Comparison of migraine patients with and without aura.
| Migraine without aura | Migraine with aura | p values | |
|---|---|---|---|
| Study population | 173 | 48 | n.a. |
| Mean age | 56.2 ± 5 years | 53.8 ± 6.4 years | 0.005 |
| Males | 59 (34.1%) | 1 (2%) | <0.001 |
| Females | 114 (65.9%) | 47 (98%) | <0.001 |
| Smoking | 48 (27.7%) | 12 (25%) | 0.14 |
| Dyslipidaemia | 31 (18%) | 9 (18.7%) | 0.89 |
| Hypertension | 92 (53.2%) | 36 (75%) | 0.006 |
| Diabetes | 20 (11.6%) | 12 (25%) | 0.019 |
| ACE inhibitors | 56 (32.3%) | 24 (50%) | 0.024 |
| ARBs | 20 (11.6%) | 8 (16.7%) | 0.34 |
| Statins | 36 (20.1%) | 4 (8.3%) | 0.04 |
| Beta-blockers | 48 (27.7%) | 20 (41.7%) | 0.06 |
| Blood pressure (Hgmm) | 137/84 | 138/82 | 0.23 |
| Cholesterol (mmol/l) | 5.21 | 5.77 | 0.02 |
| LDL (mmol/l) | 3.13 | 3.1 | 0.83 |
| GFR (ml/min) | 73.95 | 74 | 0.77 |
(ACE inhibitors: angiotensin-converting-enzyme inhibitors; ARBs: angiotensin receptor blockers; LDL: low-density lipoprotein; GFR: glomerular filtration rate).